# US 2010/0168602 A1 · Methods and systems for presenting an inhalation experience

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168602 A1
- Document ID: US20100168602A1
- Status: Published application
- Kind: A1
- Application number: 12/383,819
- Filed: 2009-03-26
- Published: 2010-07-01
- Earliest claimed: 2008-12-30
- Assignees: Searete LLC
- Inventors: Roderick A. Hyde; Robert Langer; Eric C. Leuthardt; Robert W. Lord; Elizabeth A. Sweeney; Clarence T. Tegreene; Lowell L. Wood, JR.
- Web page: https://patentgrep.com/patent/US20100168602A1

## CPC

- A61B 5/4839: {combined with drug delivery}
- A61B 5/14532: {for measuring glucose, e.g. by tissue impedance measurement}
- A61B 5/163: {by tracking eye movement, gaze, or pupil change}
- A61B 5/165: {Evaluating the state of mind, e.g. depression, anxiety}
- A61B 5/411: {Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance}
- A61B 5/4833: {Assessment of subject's compliance to treatment}
- A61B 5/486: {Biofeedback (using electroencephalography [EEG] A61B5/375)}
- A61B 5/6822: {Neck}
- A61M 11/00: Sprayers or atomisers specially adapted for therapeutic purposes (in general B05B; {aerosol containers B65D83/14})
- A61M 15/00: Inhalators {(drug delivery in endotracheal tubes A61M16/04)}
- A61M 15/02: with activated or ionised {fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices}; Ozone-inhalators {with radioactive tagged particles}
- A61M 15/08: Inhaling devices inserted into the nose
- G16H 10/20: for electronic clinical trials or questionnaires
- G16H 20/13: delivered from dispensers
- G16H 40/67: for remote operation
- A61B 5/01: Measuring temperature of body parts {; Diagnostic temperature sensing, e.g. for malignant or inflamed tissue} (clinical contact thermometers G01K13/20)
- A61B 5/02: Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B 5/024: Measuring pulse rate or heart rate
- A61B 5/11: Measuring movement of the entire body or parts thereof, e.g. head or hand tremor or mobility of a limb {(A61B5/1038 takes precedence; motion detection to correct for motion artifacts in physiological signals A61B5/721)}
- A61B 5/145: Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value {; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue} (non-radiation detecting or locating of foreign bodies in blood A61B5/06)
- A61B 5/4064: {Evaluating the brain (for intracranial pressure A61B5/031; for cerebral blood gases A61B5/14553; using EEG A61B5/369)}
- A61M 15/0028: {using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up}
- A61M 15/0065: {Inhalators with dosage or measuring devices (A61M15/0028 takes precedence; dosage devices incorporated in aerosol cans B65D83/52)}
- A61M 15/009: {using medicine packages with incorporated spraying means, e.g. aerosol cans (pocket atomiser of the injector type A61M11/08)}
- A61M 2021/0016: {by the smell sense}
- A61M 2205/3553: remote, e.g. between patient's home and doctor's office
- A61M 2205/3569: sublocal, e.g. between console and disposable
- A61M 2205/3584: using modem, internet or Bluetooth®
- A61M 2205/3592: using telemetric means, e.g. radio or optical transmission
- A61M 2205/50: with microprocessors or computers
- A61M 2205/581: by audible feedback
- A61M 2205/582: by tactile feedback
- A61M 2205/583: by visual feedback
- A61M 2205/588: by olfactory feedback, i.e. smell
- A61M 2209/088: on the body
- A61M 2230/201: Glucose concentration
- A61M 2230/205: partial oxygen pressure (P-O2)
- A63F 2300/65: for computing the condition of a game character
- A63F 2300/6692: using special effects, generally involving post-processing, e.g. blooming
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- A63F: CARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR

## Abstract

Methods, computer program products, and systems are described that include accepting at least one indication of use of an inhalation device configured to dispense a bioactive agent to an individual and presenting at least one artificial sensory experience to monitor at least one side effect of the bioactive agent on the individual.

## Claims

### Claim at position 1

1-82. (canceled)

### Claim 83

A system, comprising:
an accepter module; and
a side effect presenter module configured to present at least one artificial sensory experience to monitor at least one side effect of a bioactive agent on an individual.

### Claim 84 (depends on 83)

The system of claim 83, wherein the accepter module comprises:
a computer interface accepter module.

### Claim 85 (depends on 84)

The system of claim 84, wherein the computer interface accepter module comprises:
a wireless device accepter module.

### Claim 86 (depends on 83)

The system of claim 83, wherein the accepter module comprises:
an inhalation collar accepter module.

### Claim 87 (depends on 83)

The system of claim 83, wherein the accepter module comprises:
a virtual headset accepter module.

### Claim 88 (depends on 87)

The system of claim 87, wherein the virtual headset accepter module comprises:
a schedule accepter module.

### Claim 89 (depends on 83)

The system of claim 83, wherein the accepter module comprises:
a medication inhalation device accepter module.

### Claim 90 (depends on 89)

The system of claim 89, wherein the medication inhalation device accepter module comprises:
a prescription medication device accepter module.

### Claim 91 (depends on 90)

The system of claim 90, wherein the prescription medication device accepter module comprises:
a bioactive agent accepter module.

### Claim 92 (depends on 83)

The system of claim 83, wherein the accepter module comprises:
an unregulated bioactive agent accepter module.

### Claim 93 (depends on 92)

The system of claim 92, wherein the unregulated bioactive agent accepter module comprises:
an unregulated inhalation agent accepter module.

### Claim 94 (depends on 83)

The system of claim 83, wherein the accepter module comprises:
a recreational agent device accepter module.

### Claim 95 (depends on 94)

The system of claim 94, wherein the computer interface accepter module comprises:
a recreational bioactive agent accepter module.

### Claim 96 (depends on 83)

The system of claim 83, wherein the side effect presenter module configured to present at least one artificial sensory experience to monitor at least one side effect of a bioactive agent on an individual comprises:
an automated medical device receiver module.

### Claim 97 (depends on 96)

The system of claim 96, wherein the automated medical device receiver module comprises:
a sensate experience presenter module.

### Claim 98 (depends on 97)

The system of claim 97, wherein the sensate experience presenter module comprises:
a stimulus presenter module.

### Claim 99 (depends on 83)

The system of claim 83, wherein the side effect presenter module configured to present at least one artificial sensory experience to monitor at least one side effect of a bioactive agent on an individual comprises:
a mobile device presenter module.

### Claim 100 (depends on 83)

The system of claim 83, wherein the side effect presenter module configured to present at least one artificial sensory experience to monitor at least one side effect of a bioactive agent on an individual comprises:
a virtual object presenter module.

### Claim 101 (depends on 83)

The system of claim 83, wherein the side effect presenter module configured to present at least one artificial sensory experience to monitor at least one side effect of a bioactive agent on an individual comprises:
a physiological characteristic monitor presenter module.

### Claim 102 (depends on 83)

The system of claim 83, wherein the side effect presenter module configured to present at least one artificial sensory experience to monitor at least one side effect of a bioactive agent on an individual comprises:
a neurophysiological measurement monitor presenter module.

### Claim 103 (depends on 102)

The system of claim 102, wherein the neurophysiological measurement monitor presenter module comprises:
a neurophysiological characteristic monitor presenter module.

### Claim 104 (depends on 83)

The system of claim 83, wherein the side effect presenter module configured to present at least one artificial sensory experience to monitor at least one side effect of a bioactive agent on an individual comprises:
a brain activity measurer module.

### Claim 105 (depends on 104)

The system of claim 104, wherein the brain activity measurer module comprises:
a brain marker measurer module.

### Claim 106 (depends on 83)

The system of claim 83, wherein the side effect presenter module configured to present at least one artificial sensory experience to monitor at least one side effect of a bioactive agent on an individual comprises:
a real time presenter module.

### Claim 107 (depends on 83)

The system of claim 83, wherein the side effect presenter module configured to present at least one artificial sensory experience to monitor at least one side effect of a bioactive agent on an individual comprises:
a function output monitorer module.

### Claim 108 (depends on 83)

The system of claim 83, wherein the side effect presenter module configured to present at least one artificial sensory experience to monitor at least one side effect of a bioactive agent on an individual comprises:
a test function output monitorer module.

### Claim 109 (depends on 83)

The system of claim 83, wherein the side effect presenter module configured to present at least one artificial sensory experience to monitor at least one side effect of a bioactive agent on an individual comprises:
a recorder module.

### Claim 110 (depends on 83)

The system of claim 83, further comprising:
a reporter module.

### Claim 111 (depends on 110)

The system of claim 110, wherein the reporter module comprises:
an institution reporter module.

### Claim 112 (depends on 110)

The system of claim 110, wherein the reporter module comprises:
a third party reporter module.

### Claim 113 (depends on 110)

The system of claim 110, wherein the reporter module comprises:
a compliance reporter module.

### Claim 114 (depends on 110)

The system of claim 110, wherein the reporter module comprises:
a selective reporter module.

### Claim 115 (depends on 114)

The system of claim 114, wherein the selective reporter module comprises:
a health care provider reporter module.

### Claim 116 (depends on 83)

The system of claim 83, further comprising:
a predictor module.

### Claim 117 (depends on 116)

The system of claim 116, wherein the predictor module comprises:
an effect predictor module.

### Claim 118 (depends on 116)

The system of claim 116, wherein the predictor module comprises:
a behavioral response predictor module.